SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells
Acta Biochimica et Biophysica Sinica · 01.11.2026 · 58 (11) · 2486-2502
DOI: 10.3724/abbs.2025245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 06.02.2026. Verfasst von Wufei Ye und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Sorafenib, Carcinoma, Hepatocellular, Liver Neoplasms, Drug Resistance, Neoplasm. Die Arbeit nennt 74 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Ye, W., Chen, T., Li, Y., Luan, J., Yang, K., & Wang, S. (2026). SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells. Acta Biochimica et Biophysica Sinica, 58(11), 2486-2502. https://doi.org/10.3724/abbs.2025245
Vancouver
Ye W, Chen T, Li Y, Luan J, Yang K, Wang S. SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells. Acta Biochimica et Biophysica Sinica. 2026;58(11):2486-2502. doi:10.3724/abbs.2025245
BibTeX
@article{Ye2026,
author = {Ye, Wufei and Chen, Tao and Li, Yueran and Luan, Jiajie and Yang, Kui and Wang, Sheng},
title = {SPP1 facilitates sorafenib resistance in hepatocellular carcinoma by upregulating aerobic glycolysis in endothelial cells},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
volume = {58},
number = {11},
pages = {2486--2502},
doi = {10.3724/abbs.2025245}
}
EUVIMED